Antikörper-Formulierungen
European patent · EP2889310 · In force
Register entry
- Publication number
- EP2889310
- Application number
- EP15155712
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 3, 2008
- Published
- Jul 1, 2015
- Granted
- Dec 20, 2017
- Protection ends at the latest
- Jul 2, 2028
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C07K 16/00 (2006.01)A61K 39/395 (2006.01)C07K 16/28 (2006.01)A61K 9/00 (2006.01)
- Priority
- US 948220 P 06.07.2007
- Divided from
- EP08781323
- Filing language
- English
- Source
- Swissreg
Supplementary protection certificates
A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Aug 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2025 → 31.07.2026
Published in Swissreg on 01.08.2025
- Aug 1, 2024
Change
Published in Swissreg on 01.08.2024
- Aug 1, 2023
Change
Published in Swissreg on 01.08.2023
- Aug 1, 2022
Change
Published in Swissreg on 01.08.2022
- Dec 20, 2017
Granted
Published in Swissreg on 20.12.2017
Parties
Inventor
King of Prussia, PA 19406, US
King of Prussia, PA 19406, US
Brentford Middlesex TW8 9GS, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.